Who has been buying Zeria Pharmaceutical Co., Ltd. stock?

12 distinct investors have filed 2 disclosed large-shareholding filings in Zeria Pharmaceutical Co., Ltd. (4559), most recently on 2024-07-29. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Zeria Pharmaceutical Co., Ltd. have?

Zeria Pharmaceutical Co., Ltd. has 2 buy-side and 4 sell-side disclosures on record, covering ¥1.3B ($8.1M) in total reported value, spanning 2022-09-26 to 2024-07-29.

Do insider buys in Japanese stocks predict returns?

Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Zeria Pharmaceutical Co., Ltd. 4559

Company

ゼリア新薬工業株式会社Zeria Pharmaceutical Co., Ltd.

Investors

Buys

Total Value

¥1.3B ($8.1M)

Avg Return

+10.09%

Last Filing

2024-07-29

Zeria Pharmaceutical Co., Ltd. (4559) has 2 disclosed large-shareholding filings and 4 disclosed disposals on record, filed by 12 distinct investors. Together those filings cover ¥1.3B ($8.1M) in reported transaction value. The earliest filing StockDrifts holds for Zeria Pharmaceutical Co., Ltd. is dated 2022-09-26; the most recent is 2024-07-29. Across these filings the average return since disclosure is +10.09%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

Date	Type	Source	Insider	Purpose	Shares	Price at filing	Return	Value
2024-07-29	BUY	negotiated	株式会社三菱UFJ銀行 Mitsubishi UFJ Financial Group Inc.	strategic	2.1M	¥2,171	-	-
2024-07-29	SELL	negotiated	三菱UFJ信託銀行株式会社 Mitsubishi UFJ Financial Group Inc.	passive	956.5K	¥2,171	+6.3%	¥796M ($5.1M)
2024-07-29	BUY	negotiated	三菱UFJアセットマネジメント株式会社 Mitsubishi UFJ Financial Group Inc.	passive	171.8K	¥2,171	-6.3%	¥92M ($595K)
2024-05-16	BUY	Market Buy	有限会社伊部 Ibe	other	5.3M	¥2,000	+1.8%	¥1.2B ($7.5M)
2024-05-16	BUY	Market Buy	伊部幸顕 Yukiaki Ibe	activist	1.6M	¥2,000	-	-
2024-04-08	BUY	unknown	株式会社三井住友銀行 Sumitomo Mitsui Banking Corporation	other	1.4M	¥2,095	-	-
2024-04-08	SELL	unknown	SMBC日興証券株式会社 SMBC Nikko Securities Inc.	other	104.6K	¥2,095	+2.9%	¥556M ($3.6M)
2024-04-08	SELL	unknown	SMBCファイナンスサービス株式会社 SMBC Finance Service Co., Ltd.	other	0	¥2,095	+2.9%	¥1.9B ($12.2M)
2024-04-08	BUY	unknown	三井住友カード株式会社 Sumitomo Mitsui Card Co., Ltd.	other	900.9K	¥2,095	-	¥1.9B ($12.2M)
2022-09-26	BUY	unknown	株式会社みずほ銀行 Mizuho Bank, Ltd.	strategic	1.4M	¥1,995	-	-
2022-09-26	BUY	unknown	みずほ証券株式会社 Mizuho Securities Co., Ltd.	other	315.6K	¥1,995	-	¥630M ($4.1M)
2022-09-26	SELL	unknown	アセットマネジメントOne株式会社 Asset Management One Co., Ltd.	other	658.8K	¥1,995	-2.0%	¥1.2B ($7.9M)

Frequently asked questions

Who has been buying Zeria Pharmaceutical Co., Ltd. stock?: 12 distinct investors have filed 2 disclosed large-shareholding filings in Zeria Pharmaceutical Co., Ltd. (4559), most recently on 2024-07-29. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Zeria Pharmaceutical Co., Ltd. have?: Zeria Pharmaceutical Co., Ltd. has 2 buy-side and 4 sell-side disclosures on record, covering ¥1.3B ($8.1M) in total reported value, spanning 2022-09-26 to 2024-07-29.
Do insider buys in Japanese stocks predict returns?: Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.